Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Riki Kurokawa is active.

Publication


Featured researches published by Riki Kurokawa.


Cell | 1996

A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors

Yasutomi Kamei; Lan Xu; Thorsten Heinzel; Joseph Torchia; Riki Kurokawa; Bernd Gloss; Sheng-Cai Lin; Richard A. Heyman; David W. Rose; Christopher K. Glass; Michael G. Rosenfeld

Nuclear receptors regulate gene expression by direct activation of target genes and inhibition of AP-1. Here we report that, unexpectedly, activation by nuclear receptors requires the actions of CREB-binding protein (CBP) and that inhibition of AP-1 activity is the apparent result of competition for limiting amounts of CBP/p300 in cells. Utilizing distinct domains, CBP directly interacts with the ligand-binding domain of multiple nuclear receptors and with the p160 nuclear receptor coactivators, which upon cloning have proven to be variants of the SRC-1 protein. Because CBP represents a common factor, required in addition to distinct coactivators for function of nuclear receptors, CREB, and AP-1, we suggest that CBP/p300 serves as an integrator of multiple signal transduction pathways within the nucleus.


Nature | 1998

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

Robert T. Nolte; Wisely Gb; Westin S; J.E Cobb; Millard H. Lambert; Riki Kurokawa; Michael G. Rosenfeld; Timothy M. Willson; Christopher K. Glass; Michael V. Milburn

The peroxisome proliferator-activated receptor-γ (PPAR-γ) is a ligand-dependent transcription factor that is important in adipocyte differentiation and glucose homeostasis and which depends on interactions with co-activators, including steroid receptor co-activating factor-1 (SRC-1). Here we present the X-ray crystal structure of the human apo-PPAR-γ ligand-binding domain (LBD), at 2.2 Å resolution; this structure reveals a large binding pocket, which may explain the diversity of ligands for PPAR-γ. We also describe the ternary complex containing the PPAR-γ LBD, the antidiabetic ligand rosiglitazone (BRL49653), and 88 amino acids of human SRC-1 at 2.3 Å resolution. Glutamate and lysine residues that are highly conserved in LBDs of nuclear receptors form a ‘charge clamp’ that contacts backbone atoms of the LXXLL helices of SRC-1. These results, together with the observation that two consecutive LXXLL motifs of SRC-1 make identical contacts with both subunits of a PPAR-γ homodimer, suggest a general mechanism for the assembly of nuclear receptors with co-activators.


Nature | 2008

Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription

Xiangting Wang; Shigeki Arai; Xiaoyuan Song; Donna Reichart; Kun Du; Gabriel Pascual; Paul Tempst; Michael G. Rosenfeld; Christopher K. Glass; Riki Kurokawa

With the recent recognition of non-coding RNAs (ncRNAs) flanking many genes, a central issue is to obtain a full understanding of their potential roles in regulated gene transcription programmes, possibly through different mechanisms. Here we show that an RNA-binding protein, TLS (for translocated in liposarcoma), serves as a key transcriptional regulatory sensor of DNA damage signals that, on the basis of its allosteric modulation by RNA, specifically binds to and inhibits CREB-binding protein (CBP) and p300 histone acetyltransferase activities on a repressed gene target, cyclin D1 (CCND1) in human cell lines. Recruitment of TLS to the CCND1 promoter to cause gene-specific repression is directed by single-stranded, low-copy-number ncRNA transcripts tethered to the 5′ regulatory regions of CCND1 that are induced in response to DNA damage signals. Our data suggest that signal-induced ncRNAs localized to regulatory regions of transcription units can act cooperatively as selective ligands, recruiting and modulating the activities of distinct classes of RNA-binding co-regulators in response to specific signals, providing an unexpected ncRNA/RNA-binding protein-based strategy to integrate transcriptional programmes.


Cell | 2000

Combinatorial Roles of the Nuclear Receptor Corepressor in Transcription and Development

Kristen Jepsen; Ola Hermanson; Thandi M. Onami; Anatoli S. Gleiberman; Victoria V. Lunyak; Robert J. McEvilly; Riki Kurokawa; Vivek Kumar; Forrest C. Liu; Edward Seto; Stephen M. Hedrick; Gail Mandel; Christopher K. Glass; David W. Rose; Michael G. Rosenfeld

Transcriptional repression plays crucial roles in diverse aspects of metazoan development, implying critical regulatory roles for corepressors such as N-CoR and SMRT. Altered patterns of transcription in tissues and cells derived from N-CoR gene-deleted mice and the resulting block at specific points in CNS, erythrocyte, and thymocyte development indicated that N-CoR was a required component of short-term active repression by nuclear receptors and MAD and of a subset of long-term repression events mediated by REST/NRSF. Unexpectedly, N-CoR and a specific deacetylase were also required for transcriptional activation of one class of retinoic acid response element. Together, these findings suggest that specific combinations of corepressors and histone deacetylases mediate the gene-specific actions of DNA-bound repressors in development of multiple organ systems.


Molecular and Cellular Biology | 1999

Transcriptional Activation by NF-κB Requires Multiple Coactivators

Kelly-Ann Sheppard; David W. Rose; Zaffar K. Haque; Riki Kurokawa; Eileen M. McInerney; Stefan Westin; Dimitris Thanos; Michael G. Rosenfeld; Christopher K. Glass; Tucker Collins

ABSTRACT Nuclear factor-κB (NF-κB) plays a role in the transcriptional regulation of genes involved in inflammation and cell survival. In this report we demonstrate that NF-κB recruits a coactivator complex that has striking similarities to that recruited by nuclear receptors. Inactivation of either cyclic AMP response element binding protein (CREB)-binding protein (CBP), members of the p160 family of coactivators, or the CBP-associated factor (p/CAF) by nuclear antibody microinjection prevents NF-κB-dependent transactivation. Like nuclear receptor-dependent gene expression, NF-κB-dependent gene expression requires specific LXXLL motifs in one of the p160 family members, and enhancement of NF-κB activity requires the histone acetyltransferase (HAT) activity of p/CAF but not that of CBP. This coactivator complex is differentially recruited by members of the Rel family. The p50 homodimer fails to recruit coactivators, although the p50-p65 heterodimeric form of the transcription factor assembles the integrator complex. These findings provide new mechanistic insights into how this family of dimeric transcription factors has a differential effect on gene expression.


Nature | 1998

Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.

Westin S; Riki Kurokawa; Nolte Rt; Wisely Gb; Eileen M. McInerney; David W. Rose; Michael V. Milburn; Michael G. Rosenfeld; Christopher K. Glass

Retinoic-acid receptor-α (RAR-α) and peroxisome proliferator-activated receptor-γ (PPAR-γ) are members of the nuclear-receptor superfamily that bind to DNA as heterodimers with retinoid-X receptors (RXRs),. PPAR–RXR heterodimers can be activated by PPAR or RXR ligands, whereas RAR–RXR heterodimers are selectively activated by RAR ligands only, because of allosteric inhibition of the binding of ligands to RXR by RAR,. However, RXR ligands can potentiate the transcriptional effects of RAR ligands in cells. Transcriptional activation by nuclear receptors requires a carboxy-terminal helical region, termed activation function-2 (AF-2) (refs 7,8,9), that forms part of the ligand-binding pocket and undergoes a conformational change required for the recruitment of co-activator proteins, including NCoA-1/SRC-1 (refs 10,11,12,13,14,15,16,17). Here we show that allosteric inhibition of RXR results from a rotation of the RXR AF-2 helix that places it in contact with the RAR coactivator-binding site. Recruitment of an LXXLL motif of SRC-1 to RAR in response to ligand displaces the RXR AF-2 domain, allowing RXR ligands to bind and promote the binding of a second LXXLL motif from the same SRC-1 molecule. These results may partly explain the different responses of nuclear-receptor heterodimers to RXR-specific ligands.


Nature | 1998

Signal-specific co-activator domain requirements for Pit-1 activation

Lan Xu; Robert M. Lavinsky; Jeremy S. Dasen; Sarah E. Flynn; Eileen M. McInerney; Tina-Marie Mullen; Thorsten Heinzel; Daniel P. Szeto; Edward Korzus; Riki Kurokawa; Aneel K. Aggarwal; David W. Rose; Christopher K. Glass; Michael G. Rosenfeld

POU-domain proteins, such as the pituitary-specific factor Pit-1, are members of the homeodomain family of proteins which are important in development and homeostasis, acting constitutively or in response to signal-transduction pathways to either repress or activate the expression of specific genes. Here we show that whereas homeodomain-containing repressors such as Rpx seem to recruit only a co-repressor complex, the activity of Pit-1 (ref. 3) is determined by a regulated balance between a co-repressor complex that contains N-CoR/SMRT,, mSin3A/B and histone deacetylases and a co-activator complex that includes the CREB-binding protein (CBP) and p/CAF. Activation of Pit-1 by cyclic AMP or growth factors depends on distinct amino- and carboxy-terminal domains of CBP, respectively. Furthermore, thehistone acetyltransferase functions of CBP, or p/CAF are required for Pit-1 function that is stimulated by cyclic AMP or growth factors, respectively. These data show that there is a switch in specific requirements for histone acetyltransferases and CBP domains in mediating the effects of different signal-transduction pathways on specific DNA-bound transcription factors.


Molecular and Cellular Biology | 1997

Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.

J DiRenzo; Mats Söderström; Riki Kurokawa; Mh Ogliastro; Mercedes Ricote; S Ingrey; Michael G. Rosenfeld; Christopher K. Glass

As the obligate member of most nuclear receptor heterodimers, retinoid X receptors (RXRs) can potentially perform two functions: cooperative binding to hormone response elements and coordinate regulation of target genes by RXR ligands. In this paper we describe allosteric interactions between RXR and two heterodimeric partners, retinoic acid receptors (RARs) and peroxisome proliferator-activated receptors (PPARs); RARs and PPARs prevent and permit activation by RXR-specific ligands, respectively. By competing for dimerization with RXR on response elements consisting of direct-repeat half-sites spaced by 1 bp (DR1 elements), the relative abundance of RAR and PPAR determines whether the RXR signaling pathway will be functional. In contrast to RAR, which prevents the binding of RXR ligands and recruits the nuclear receptor corepressor N-CoR, PPAR permits the binding of SRC-1 in response to both RXR and PPAR ligands. Overexpression of SRC-1 markedly potentiates ligand-dependent transcription by PPARgamma, suggesting that SRC-1 serves as a coactivator in vivo. Remarkably, the ability of RAR to both block the binding of ligands to RXR and interact with corepressors requires the CoR box, a structural motif residing in the N-terminal region of the RAR ligand binding domain. Mutations in the CoR box convert RAR from a nonpermissive to a permissive partner of RXR signaling on DR1 elements. We suggest that the differential recruitment of coactivators and corepressors by RAR-RXR and PPAR-RXR heterodimers provides the basis for a transcriptional switch that may be important in controlling complex programs of gene expression, such as adipocyte differentiation.


PLOS Genetics | 2010

Id4, a New Candidate Gene for Senile Osteoporosis, Acts as a Molecular Switch Promoting Osteoblast Differentiation

Yoshimi Tokuzawa; Ken Yagi; Yzumi Yamashita; Yutaka Nakachi; Itoshi Nikaido; Hidemasa Bono; Yuichi Ninomiya; Yukiko Kanesaki-Yatsuka; Masumi Akita; Hiromi Motegi; Shigeharu Wakana; Tetsuo Noda; Fred Sablitzky; Shigeki Arai; Riki Kurokawa; Toru Fukuda; Takenobu Katagiri; Christian Schönbach; Tatsuo Suda; Yosuke Mizuno; Yasushi Okazaki

Excessive accumulation of bone marrow adipocytes observed in senile osteoporosis or age-related osteopenia is caused by the unbalanced differentiation of MSCs into bone marrow adipocytes or osteoblasts. Several transcription factors are known to regulate the balance between adipocyte and osteoblast differentiation. However, the molecular mechanisms that regulate the balance between adipocyte and osteoblast differentiation in the bone marrow have yet to be elucidated. To identify candidate genes associated with senile osteoporosis, we performed genome-wide expression analyses of differentiating osteoblasts and adipocytes. Among transcription factors that were enriched in the early phase of differentiation, Id4 was identified as a key molecule affecting the differentiation of both cell types. Experiments using bone marrow-derived stromal cell line ST2 and Id4-deficient mice showed that lack of Id4 drastically reduces osteoblast differentiation and drives differentiation toward adipocytes. On the other hand knockdown of Id4 in adipogenic-induced ST2 cells increased the expression of Pparγ2, a master regulator of adipocyte differentiation. Similar results were observed in bone marrow cells of femur and tibia of Id4-deficient mice. However the effect of Id4 on Pparγ2 and adipocyte differentiation is unlikely to be of direct nature. The mechanism of Id4 promoting osteoblast differentiation is associated with the Id4-mediated release of Hes1 from Hes1-Hey2 complexes. Hes1 increases the stability and transcriptional activity of Runx2, a key molecule of osteoblast differentiation, which results in an enhanced osteoblast-specific gene expression. The new role of Id4 in promoting osteoblast differentiation renders it a target for preventing the onset of senile osteoporosis.


RNA Biology | 2009

Transcriptional regulation through noncoding RNAs and epigenetic modifications

Riki Kurokawa; Michael G. Rosenfeld; Christopher K. Glass

The recognition that substantial portions of the “noncoding (nc)” regions of metazoan genomes are transcribed has generated intense interest in the potential biological roles of ncRNAs. Gene silencing has emerged as one of the major functions of short double stranded ncRNAs (22~25 nucleotides, nt) that are generated by specific processing machinery. Transcription is also regulated by other classes of ncRNAs, including long (more than 200 nt), single-stranded, polyadenylated RNA molecules. Here, we review recent studies suggesting that some ncRNAs appear to function by binding to and regulating the activities of transcriptional co-activator or co-repressor complexes. Although the extents to which these mechanisms are used remains to be established, the identification of highly conserved ncRNAs and the presence of RNA binding domains in a large number of transcriptional co-regulators raise the possibility that ncRNA/coregulator interactions play broad roles in the regulation of gene expression.

Collaboration


Dive into the Riki Kurokawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David W. Rose

University of California

View shared research outputs
Top Co-Authors

Avatar

Shigeki Arai

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Takanori Oyoshi

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lan Xu

University of California

View shared research outputs
Top Co-Authors

Avatar

Joseph Torchia

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Hiromi Oda

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Kazuhiro Yokota

Saitama Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge